I’m not overly concerned at this point either. I

I’m not overly concerned at this point either. I do not think they plan to license cancer and only want to license HIV and GvHD. Even if they don’t license anything other than PCa I would be okay with that if they get enough upfront cash to build a sufficient team. I’m sure HIV penetration may be slower or less than if licensed, but as your previous article noted those companies that go alone often make more revenues even with lower sales. I think cancer will sell itself and once worldwide news is made will help with HIV sales also.

I’m not going anywhere, but need this stock price to go back up a little before I take a second mortgage out!

Please do your own due diligence. All my posts and comments are not to be considered investment advice.